Frequency of Infection with Postpartum Intrauterine Contraceptive Device
DOI:
https://doi.org/10.70749/ijbr.v3i6.1814Keywords:
Postpartum Intrauterine Contraceptive Device, Infection, Copper IUD.Abstract
Background: Postpartum intrauterine contraceptive device insertion is a valuable strategy for immediate postpartum contraception, offering convenience and long-term protection. Despite its clinical benefits, concerns regarding post-insertion infections persist, necessitating further evaluation of associated risks in local populations. Objective: To determine the frequency of infection with postpartum intrauterine contraceptive device. Study Design: Descriptive observational study. Duration and Place of Study: The study was conducted from September 2024 to March 2025 at the Department of Obstetrics and Gynaecology, Mardan Medical Complex, Mardan. Methodology: A total of 117 postpartum women aged 25–45 years with singleton pregnancies and parity of three or more were enrolled. All received copper-bearing IUDs within 48 hours post-delivery via either vaginal or cesarean route. Participants were followed for 30 days’ post-insertion to assess infection, defined through specific laboratory criteria. Results: The mean age of participants was 34.78 ± 6.08 years, and most were urban residents and multiparous. Infection following PPIUCD insertion occurred in 8.5% of cases. While higher infection rates were observed among women over 30 years of age and those with vaginal deliveries, no statistically significant associations were found with any demographic or clinical variable. Conclusion: PPIUCD insertion postpartum is generally safe and well-tolerated, with a low incidence of infection and no significant demographic predictors of risk.
Downloads
References
1. Mare, K. U., Aychiluhm, S. B., Tadesse, A. W., & Abdu, M. (2022). Married women’s decision-making autonomy on contraceptive use and its associated factors in Ethiopia: A multilevel analysis of 2016 demographic and health survey. SAGE Open Medicine, 10.
https://doi.org/10.1177/20503121211068719
2. Durante, J. C., Sims, J., Jarin, J., Gold, M. A., Messiah, S. E., & Francis, J. K. (2023). Long-acting reversible contraception for adolescents: A review of practices to support better communication, counseling, and adherence. Adolescent Health, Medicine and Therapeutics, 14, 97-114.
https://doi.org/10.2147/ahmt.s374268
3. Tesfaw, M., Abebe, A., Bekele, B., & Baza, D. (2022). The lived experience of women using bilateral tubal ligation service in rural Southern Ethiopia: A phenomenological study. Open Access Journal of Contraception, 13, 49-60.
https://doi.org/10.2147/oajc.s359120
4. Sharif, A. B., Hasan, M. T., Naziat, M. H., Zerin, T., & Kundu, S. (2023). Permanent, long-acting and short-acting reversible contraceptive methods use among women in Bangladesh: An analysis of Bangladesh demographic and health survey 2017–2018 data. BMJ Open, 13(7), e073469.
https://doi.org/10.1136/bmjopen-2023-073469
5. Rana, A., Shrestha, A., Regmi, A., Aryal, S., Karki, P., & Singh, R. (2022). Intrauterine pregnancy with copper intrauterine contraceptive device in situ: A case report from Nepal. Annals of Medicine & Surgery, 82.
https://doi.org/10.1016/j.amsu.2022.104781
6. Yan, M., Zhang, Y., Wu, Z., Li, Y., Dou, K., Wang, B., Wang, Y., & Zhou, Q. (2022). Recent progress in advanced biomaterials for long-acting reversible contraception. Journal of Nanobiotechnology, 20(1).
https://doi.org/10.1186/s12951-022-01329-5
7. Terefe, G., Wakjira, D., & Abebe, F. (2023). Immediate postpartum intrauterine contraceptive device use among pregnant women attending antenatal clinics in Jimma town public healthcare facilities, Ethiopia: Intentions and barriers. SAGE Open Medicine, 11.
https://doi.org/10.1177/20503121231157212
8. Sisay, F. A., Ayalew, A. B., Erega, B. B., & Ferede, W. Y. (2023). Factors associated with knowledge of the postpartum intrauterine contraceptive device and attitude towards its use among women attending antenatal care at Debre Tabor town, northwest Ethiopia, 2021: A cross-sectional study. Contraception and Reproductive Medicine, 8(1).
https://doi.org/10.1186/s40834-022-00202-y
9. Nalini, N., Singh, B., Jha, S., & Singh, A. V. (2023). Acceptance, safety and efficacy of postpartum intrauterine contraceptive device. Journal of Family Medicine and Primary Care, 12(5), 868-873.
https://doi.org/10.4103/jfmpc.jfmpc_1392_22
10. Fassett, M. J., Reed, S. D., Rothman, K. J., Pisa, F., Schoendorf, J., Wahdan, Y., Peipert, J. F., Gatz, J., Ritchey, M. E., Armstrong, M. A., Raine-Bennett, T., Postlethwaite, D., Getahun, D., Shi, J. M., Xie, F., Chiu, V. Y., Im, T. M., Takhar, H. S., Wang, J., … Anthony, M. S. (2023). Risks of uterine perforation and expulsion associated with intrauterine devices. Obstetrics & Gynecology, 142(3), 641-651.
https://doi.org/10.1097/aog.0000000000005299
11. Rosa Bolling, K., Wahdan, Y., Warnock, N., Lott, J., Schoendorf, J., Pisa, F., Gomez-Espinosa, E., Kistler, K., & Maiese, B. (2022). Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: A systematic literature review. BMJ Sexual & Reproductive Health, 49(2), e1-e1.
https://doi.org/10.1136/bmjsrh-2022-201579
12. Hussaini, M. S., Tabib, N. A., Baker, M., Omale, M., & Nahidi, S. M. (2022). Intrauterine contraceptive device complicated by a pelvic abscess: A case report. Cureus.
https://doi.org/10.7759/cureus.30728
13. Herculano, T. B., Surita, F. G., Juliato, C. R., & Rehder, P. M. (2022). Comparison between two methods of the immediate post-placental insertion of copper intrauterine device in vaginal birth—a protocol for a randomized clinical trial. Trials, 23(1).
https://doi.org/10.1186/s13063-022-07041-x
14. Kassa, B. G., Ayele, A. D., Belay, H. G., Tefera, A. G., Tiruneh, G. A., Ayenew, N. T., Mihiretie, G. N., Tenaw, L. A., Semahegn, A. M., & Worku, M. D. (2021). Postpartum intrauterine contraceptive device use and its associated factors in Ethiopia: Systematic review and meta-analysis. Reproductive Health, 18(1).
https://doi.org/10.1186/s12978-021-01273-x
15. Benish, K., Mala Jitendra, S., & Areesha Kamran, K. (2018). Immediate postplacental insertion of intrauterine contraceptive device (copper 375) and its complications in term of expulsion, infection and perforation. Clinical Journal of Obstetrics and Gynecology, 1(2), 082-086.
https://doi.org/10.29328/journal.cjog.1001014
16. Nisar, N., Dars, S., Awan, S., & Jokhio, F. (2020). Post-partum intrauterine contraceptive device: experience from tertiary care hospital in sindh Province Pakistan. Journal of Liaquat University of Medical & Health Sciences, 19(03), 162-166.
http://ojs.lumhs.edu.pk/index.php/jlumhs/article/view/395
17. Rehman, M., Akhtar, O., Yasmin, H., & Majid, E. (2022). Acceptance of Postpartum Intrauterine Contraceptive Device as a Method of Contraception in a Tertiary Care Hospital, Karachi. Journal of The Society of Obstetricians and Gynaecologists of Pakistan, 12(2), 91-94.
https://jsogp.net/index.php/jsogp/article/view/474
18. Khalid, H., Syed, S. Z., Waheed, F., Iqbal, F., Mehmud, Q., & Khalid, A. (2023). Comparison of complication of postpartum intrauterine contraceptive device with interval placed IUCD. Pakistan Journal of Health Sciences, 36-40.
https://doi.org/10.54393/pjhs.v4i10.1018
19. Mushtaque A, IJRCOG-9907 O. Safety and feasibility of postpartum IUCD. Int J Reprod Contracept Obstet Gynecol. 2019;8(7)
20. Abbas, S., Anwar, S., Essa Bhattani, K., Khanum Wazir, Z., & Babar, R. (2021). Prevalence of complications after interval postpartum intrauterine device insertion. Pakistan Journal of Medical and Health Sciences, 15(9), 2785-2788.
https://doi.org/10.53350/pjmhs211592785
21. Awan S, Ahmed M, Nisar H, Noreen K, Javed A, Huma Z. Clinical outcomes and complications of PPIUCD. Int J Reprod Contracept Obstet Gynecol. 2020;9(4)
22. Kumar S, Sethi R, Balasubramaniam S, Charurat E, Lalchandani K, Semba R, et al. Multicentric evaluation of PPIUCD under RMNCH+A strategy in India. BMC Health Serv Res. 2018;18
23. Iram N, Naheed A, Ali A, Shahid H, Imran K, Zulfiqar M. Retention and satisfaction of PPIUCD in tertiary care. Med Int J. 2021
24. Arif N, Zafar B, Ahmed RQ, Shehzad F. Comparison of safety and efficacy of PPIUCD with interval IUCD. Pak Armed Forces Med J. 2020;70(5):1419–23
25. Hafeez M, Sheikh M, Yousaf T, Noreen N, Shabbir S, Farooq S. Complication rates in intra-cesarean vs vaginal PPIUCD insertions. Med J. 2022;32(4):79–83
26. Syed, Z. H., Matloob, M., Qasim, R., & Najeeb, W. (2021). Infection and expulsion rate of intrauterine contraceptive device after post caesarean vs interval insertion. Pakistan Journal of Medical and Health Sciences, 15(5), 906-909.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
